Literature DB >> 5797780

Relation between plasma lignocaine levels and induced haemodynamic changes.

P F Binnion, G Murtagh, A M Pollock, E Fletcher.   

Abstract

Intravenous lignocaine (1 mg./kg. body weight) was found to produce insignificant haemodynamic changes, and in particular no reduction in myocardial contractility. A rate of 2 mg./minute infused intravenously is suggested for therapeutic purposes.In anaesthetized dogs an infusion of 13.5 mg./minute caused moderate haemodynamic depression and a maximum plasma level of 7 mug./ml. Massive injections of 200 and 400 mg. of lignocaine produced a maximum plasma level of 13.8 and 27.8 mug./ml., respectively, and in the latter failure of myocardial contraction in the presence of a normal E.C.G. ensued ("pump failure"). Lignocaine appears to alter the uptake of calcium by myocardial sarcoplasmic reticulum, and this may explain the negative inotropic effect of large doses.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5797780      PMCID: PMC1984135          DOI: 10.1136/bmj.3.5667.390

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  Calcium uptake activity of canine myocardial sarcoplasmic reticulum in the presence of anesthetic agents.

Authors:  R F Lain; M L Hess; E W Gertz; F N Briggs
Journal:  Circ Res       Date:  1968-11       Impact factor: 17.367

2.  Plasma-levels of lignocaine after intramuscular injection.

Authors:  D B Scott; P J Jebson; C W Vellani; D G Julian
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

3.  Hemodynamic effects of lidocaine in patients with heart disease.

Authors:  R R Schumacher; A D Lieberson; R H Childress; J F Williams
Journal:  Circulation       Date:  1968-06       Impact factor: 29.690

4.  Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease.

Authors:  R Gianelly; J O von der Groeben; A P Spivack; D C Harrison
Journal:  N Engl J Med       Date:  1967-12-07       Impact factor: 91.245

5.  Haemodynamic effects of lignocaine in acute myocardial infarction.

Authors:  M Stannard; G Sloman; L Sangster
Journal:  Br Med J       Date:  1968-05-25

6.  Toxic effects of lignocaine on the circulation.

Authors:  P F Binnion
Journal:  Br Med J       Date:  1968-05-25

7.  [Ca++] and [K+] interrelations influencing mechanical and electrical events in cardiac activity.

Authors:  Y C Lee; H G Richman; M B Visscher
Journal:  Am J Physiol       Date:  1966-03
  7 in total
  7 in total

1.  Effect of lignocaine on conducting system of human heart.

Authors:  S Bekheit; J G Murtagh; P Morton; E Fletcher
Journal:  Br Heart J       Date:  1973-03

2.  Atrial and ventricular pacing after open heart surgery.

Authors:  J D Wisheart; J E Wright; F L Rosenfeldt; J K Ross
Journal:  Thorax       Date:  1973-01       Impact factor: 9.139

3.  Apex cardiogram and systolic time intervals in acute myocardial infarction.

Authors:  S R Jain; J Lindahl
Journal:  Br Heart J       Date:  1971-07

4.  Lignocaine overdose and ampoule labelling.

Authors:  P P Mayer
Journal:  Br Med J       Date:  1972-07-29

Review 5.  Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.

Authors:  C P Denaro; N L Benowitz
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 6.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

7.  Disopyramide and lignocaine. A comparison of cardiac effects using echocardiography.

Authors:  M A Martin; N D Bax; G T Tucker; J W Ward
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.